Initial Observations on the COVID-19 Pandemic

What if there was a digital tool that could close the loop between patient and provider, using data to improve diagnosis and treatment? Read how Vynamic addressed that question for a Life Sciences client by providing the leadership to make this concept a reality.

A global Life Sciences company wanted to reinvent its commercial business model and disrupt the overall healthcare industry by operating more like a nimble biotech. To do so, the company engaged with Vynamic to develop an innovation capability that would allow it to run agile experiments and quickly learn from both the successes and failures while identifying potential solutions. Read how Vynamic established the value proposition, framework, and team structure to enable this innovative capability, while also providing the overall program monitoring and control.

A pre-commercial Cell and Gene Therapy client was preparing for the launch of its first product. Read how the newly formed Market Access team contacted Vynamic to assist with strategic planning and process development to support an innovative, outcomes-driven approach for value based contracting arrangements.